208 related articles for article (PubMed ID: 6153156)
21. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
[TBL] [Abstract][Full Text] [Related]
22. Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant.
Matous-Malbohan I; Holub M; Krásenská J; Marĕs V; Lodin Z
Cell Immunol; 1974 Jun; 12(3):350-62. PubMed ID: 4142422
[No Abstract] [Full Text] [Related]
23. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
Hinrichs DJ; Roberts CM; Waxman FJ
J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
[TBL] [Abstract][Full Text] [Related]
24. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
Frost H; Swanborg RH
Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
[TBL] [Abstract][Full Text] [Related]
25. Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
Javed NH; Gienapp I; Cox K; Whitacre CC
Ann N Y Acad Sci; 1996 Feb; 778():393-4. PubMed ID: 8611001
[No Abstract] [Full Text] [Related]
26. Non-encephalitogenic synthetic analogues of the determinant for allergic encephalomyelitis in guinea pigs.
Hashim GA; Sharpe RD
Nature; 1975 Jun; 255(5508):484-5. PubMed ID: 49022
[No Abstract] [Full Text] [Related]
27. Strain differences in susceptibility to experimental allergic encephalomyelitis and the immune response to the encephalitogenic determinant in inbred guinea pigs.
Teitelbaum D; Webb C; Arnon R; Sela M
Cell Immunol; 1977 Mar; 29(2):265-71. PubMed ID: 67899
[No Abstract] [Full Text] [Related]
28. Immune protection against experimental autoimmune encephalomyelitis: optimal conditions and analysis of mechanism.
Coates A; Mackay IR; Crawford M
Cell Immunol; 1974 Jun; 12(3):370-81. PubMed ID: 4142423
[No Abstract] [Full Text] [Related]
29. Experimental allergic encephalomyelitis in guinea pigs. Influence of thymosin fraction V on the disease.
Woyciechowska J; Goldstein AL; Driscoll B
J Neuroimmunol; 1985 Jan; 7(4):215-9. PubMed ID: 2578135
[TBL] [Abstract][Full Text] [Related]
30. Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells.
Hofstetter HH; Shive CL; Forsthuber TG
J Immunol; 2002 Jul; 169(1):117-25. PubMed ID: 12077236
[TBL] [Abstract][Full Text] [Related]
31. Non-encephalitogenic antigen-induced suppression and reversal of allergic encephalomyelitis.
Hashim GA
Nature; 1975 Aug; 256(5518):953-5. PubMed ID: 52118
[No Abstract] [Full Text] [Related]
32. Myelin basic protein.
Day ED
Contemp Top Mol Immunol; 1981; 8():1-39. PubMed ID: 6166428
[No Abstract] [Full Text] [Related]
33. Abrogation of resistance to the reinduction of experimental allergic encephalomyelitis by pertussigen.
Waxman FJ; Bergman RK; Munoz JJ
Cell Immunol; 1982 Sep; 72(2):375-83. PubMed ID: 6185237
[No Abstract] [Full Text] [Related]
34. Myelin basic protein: structure, function and antigenic determinants.
Hashim GA
Immunol Rev; 1978; 39():60-107. PubMed ID: 75170
[No Abstract] [Full Text] [Related]
35. Inhibition of experimental allergic encephalomyelitis in rats severely depleted of T cells.
Gonatas NK; Howard JC
Science; 1974 Nov; 186(4166):839-41. PubMed ID: 4143378
[TBL] [Abstract][Full Text] [Related]
36. Oligoclonal IgG in the cerebrospinal fluid of guinea pigs with experimental allergic encephalomyelitis.
Iivanainen M; Driscoll B; Richert J; Leon M; Chu A; Kies M; Brown B; Wallen W; Madden D; Sever J
Proc Soc Exp Biol Med; 1982 Dec; 171(3):272-5. PubMed ID: 6184726
[No Abstract] [Full Text] [Related]
37. Modulation of experimental allergic encephalomyelitis by a host-versus-graft reaction: a clinicopathological study.
Staykova M; Kozovska M; Shikova E; Goranov I
J Neuroimmunol; 1989 Dec; 25(2-3):117-23. PubMed ID: 2479657
[TBL] [Abstract][Full Text] [Related]
38. Neuroimmunologic disease: experimental and clinical aspects.
Paterson PY; Day ED
Hosp Pract; 1979 Jul; 14(7):49-58. PubMed ID: 90005
[No Abstract] [Full Text] [Related]
39. CELLULAR ACTIVITIES IN HYPERSENSITIVE REACTIONS. IV. SPECIFICALLY REACTIVE CELLS IN DELAYED HYPERSENSITIVITY: ALLERGIC ENCEPHALOMYELITIS.
RAUCH HC; RAFFEL S
J Immunol; 1964 Dec; 93():960-4. PubMed ID: 14241771
[No Abstract] [Full Text] [Related]
40. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
Raziuddin S; Kibler RF; Morrison DC
J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
